MOC HEM - General Hematopathology (Mandatory 50-Question Module)

Similar documents
MOC HEM - General Hematopathology (Mandatory 50-Question Module)

Hematology Page 1 of 8

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

Integrated Hematopathology. Morphology and FCI with IHC

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019

3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition

Contents. vii. Preface... Acknowledgments... v xiii

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Contents. Section Editor David Blomberg, MD

2/13/2015. Hematopoiesis: Red and white marrow. Fluorescent in situ hybridization for chromosomal translocation. Hematopoiesis

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

Recommended Timing for Transplant Consultation

2013 Pathology Student

Non-Hodgkin Lymphoma. Protocol applies to non-hodgkin lymphoma involving any organ system except the gastrointestinal tract.

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology

بسم هللا الرحمن الرحيم

Pathology of Hematopoietic and Lymphoid tissue

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Hematopathology Lab. Third year medical students

Recommended Curriculum for Teaching Hematopathology to Subspecialty Hematopathology Fellows

Contractor Name: Novitas Solutions, Inc. Contractor Number: Contractor Type: MAC A. LCD ID Number: L35032 Status: A-Approved

Disorders of Blood Cells & Blood Coagulation

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

2013 AAIM Pathology Workshop

Hepatic Lymphoma Diagnosis An Algorithmic Approach

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

Index. Note: Page numbers of article titles are in boldface type.

Pathology of Hematopoietic and Lymphoid tissue

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College

Introduction: The Revised (4 th Edition) World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues

Practical Diagnosis of Hematologic Disorders. Vol 2 Malignant Disorders

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

Leukocytosis - Some Learning Points

Hematology Unit Lab 2 Review Material

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Heme 9 Myeloid neoplasms

Osteosclerotic Myeloma (POEMS Syndrome)

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

Leukocyte Disorders. Dr Alauldeen Mudhafar Zubair

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual

Hemostatic System - general information

2016 WHO CLASSIFICATION OF TUMOURS OF HAEMATOPOIETIC AND LYMPHOID TISSUES, 4TH ED., VOL FCDS WEBCAST SERIES OCTOBER 19, 2017

Classifications of lymphomas

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

HEMATOPATHOLOGY SERVICES

Small B-cell (Histologically Low Grade) Lymphoma

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Common Consultations in Outpatient Hematology in 30 mins. Lala Cornelius, MD

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Approach To Leucocytosis

Hematopathology Case Study

Hematology 101. Rachid Baz, M.D. 5/16/2014

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

Diseases Of The Blood

Index. Note: Page numbers of article titles are in boldface type.

Blood Cell Identification: 2011-B Mailing: Acute Myeloid Leukemia (AML)

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

DETERMINATION OF A LYMPHOID PROCESS

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

Session 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Blood Cell Morphology. Pr François MULLIER, Pr Bernard CHATELAIN BHS course, October 12th, 2013

HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING. Use of IHC. Use of Polymerase Chain Reaction (PCR) Use of Flow Cytometry

The spectrum of flow cytometry of the bone marrow

Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

Pediatric Hematology-Oncology

Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307

Hematology Oncology Fellowship Self-Assessment of Knowledge Base and Skills

2 Principles of Blood Collection...

Contents SECTION 1: PHYSIOLOGY OF BLOOD

SESSION 1 Reactive cytopenia and dysplasia

Transcription:

MOC HEM - General Hematopathology (Mandatory 50-Question Module) acute monoblastic/monocytic leukemia infectious mononucleosis adult T cell leukemia/lymphoma in situ follicular lymphoma ALL; phenotypes large B-cell lymphoma and variants AML; cytogenetics; immunophenotypes lymphoma, differential diagnosis amyloidosis mantle cell lymphoma, FISH Anaplasma/Ehrlichia mastocytosis autoimmune lymphoproliferative syndrome May-Hegglin anomaly B cells differentiation; IgM micromegakaryocytes BCR/ABL FISH mycosis fungoides & Sezary syndrome bite RBCs myelodysplastic syndromes burr RBCs myeloproliferative neoplasms CSF; malignant cells paroxysmal nocturnal hemoglobinuria DIC pediatric follicular lymphomas essential thrombocythemia, JAK negative plasma cell neoplasms extranodal NK/T-cell lymphoma, nasal type platelet aggregation; ASA factor inhibitors Rosai-Dorfman flow cytometry, CML SOX11 follicular lymphoma t(11;14); techniques for detection GI follicular lymphoma T cell prolymphocytic leukemia hairy cell leukemia Von Willebrand disease Hb S; related disorders zinc toxic effects Hodgkin lymphoma classification

MOC HEM Blood & Bone Marrow Pathology (Elective 50-Question Module) abnormal RBC morphology; inclusions Kostmann syndrome acute leukemia of ambiguous lineage liver disease acute myelomonocytic leukemia lymphoplasmacytic lymphoma Alder-Reilly anomaly malaria AML; FISH megaloblastic anemia amyloidosis metastatic neoplasms B-lymphoblastic leukemia; FISH myelodysplastic syndromes; cytogenetics bacterial infections; WBC morphology myeloproliferative neoplasms blood and bone marrow cell identification non-immune hemolytic anemias bone marrow cell identification Parvovirus chronic myelogenous leukemia PDGFRB rearrangements congenital anemias peripheral blood; immature cells copper deficiency peripheral blood; non-hematopoietic cells delta check; misidentified specimen plasma cell myeloma Dohle bodies platelet morphology erythrocytic parasites polycythemia vera erythroid hyperplasia pseudo-chediak Higashi anomaly FISH vs. classical cytogenetics reactive lymphocytosis; WBC infections HbE disorders renal osteodystrophy hematogones rouleaux hemoglobin analysis; HPLC routine and special histologic stains hemolytic disease of the newborn serous atrophy hemophagocytic syndrome sickle solubility test iron deficiency anemia storage disorders; Gaucher disease juvenile myelomonocytic leukemia

MOC HEM Flow Cytometry (Elective 50-Question Module) aberrant antigen expression in CLL large granular lymphocytic leukemia acute myelomonocytic leukemia lymphoid hyperplasia; mantle zone acute promyelocytic leukemia lymphoid neoplasms with eosinophilia anaplastic large cell lymphoma mantle cell lymphoma angioimmunoblastic T-cell lymphoma mature T lymphocytes, immunophenotypes autoimmune disorders mature T-cell neoplasms basophils mycosis fungoides & Sezary syndrome B lymphoblastic leukemia/lymphoma myeloid antigens B-cell differentiation sequence NK/T-cell lymphomas CD3; ALL plasma cell leukemia chronic granulomatous disease plasma cell myeloma CLL/SLL; pleural fluid PNH CLL; ZAP 70 quality control CML (BCR-ABL1+) SOX-11 dead cells splenic marginal zone lymphoma EMA binding test T cell maturation follicular lymphoma T-gamma lymphocytosis hematogones T-lymphoblastic leukemia/lymphoma infectious mononucleosis large B-cell lymphoma variants

MOC HEM Hemostasis & Thrombosis (Elective 50-Question Module) abciximab international normalized ratio amyloidosis lupus anticoagulant/inhibitor aspirin and platelet function macrothrombocytopenia; genetic defect Bernard-Soulier syndrome mixing studies calibration curve; Protein C PFA 100; closure times clopidogrel platelet aggregation; abciximab clopidogrel; thromboelastometry platelet aggregation; sample collection and processing coagulation factors and pregnancy platelet P2Y12 receptor coagulation testing; heparin proficiency testing performance coagulation testing; serum Prothrombin C20209T mutation; fluorescence resonance energy transfer analysis dabigatran prothrombin genotyping, FRET analysis direct thrombin inhibitors quantitative D-dimer dysfibrinogenemia reticulated platelet counts factor assays; interpretation secondary wave of platelet aggregation factor deficiencies thromboelastograph tracings factor deficiencies; TEG tirofiban; platelet aggregation factor inhibitors TTP factor IX deficiency validation of new reagent lots Glanzmann thrombasthenia von Willebrand disease, types GPIIIa von Willebrand disease; multimer analysis heparin induced thrombocytopenia warfarin ingestion heparin therapeutic range warfarin monitoring, argatroban therapy

MOC HEM Laboratory Hematology - No Coag (Elective 50-Question Module) acanthocytes iron deficiency anemia acute monoblastic/monocytic leukemia leukemoid reaction bite cells lipemia; automated blood counts CLIA; moderate vs. high complexity testing MCV cold agglutinins megaloblastic anemia computer interoperability; interfaces monocytes cryoglobulinemia MSDS sheets CSF; non-hematopoietic cells neonatal blood Dohle bodies non-immune hemolytic anemia FDA testing regulations Pelger-Huet anomaly giant platelets; spurious automated counts pertussis Hb C disorders plasma cell myeloma Hb E disorders platelet satellitosis Hb S disorders pseudothrombocytopenia Heinz bodies quality control; moving averages hemoglobinopathy analysis RBC parasites hemoglobinopathy/thalassemia splenectomy; RBC morphology hemolytic uremic syndrome supravital stains Hgb A2 quantitation target RBCs histoplasmosis thalassemias immune hemolytic anemia thrombocytosis; spurious lab results infectious mononucleosis types of data

MOC HEM Lymph Node & Related Tissues (Elective 50-Question Module) 7q loss lymphoid hyperplasia; IHC angioimmunoblastic T-cell lymphoma lymphoma karyotypes autoimmune disorders; LNs lymphoplasmacytic lymphoma CLL/SLL MALT lymphomas; cytogenetics CLL/SLL; IHC and flow cytometry mantle cell lymphoma cutaneous T-cell lymphomas mediastinal neoplasms CXCL13 immunostain metastatic neoplasms dendritic cells, IHC mycosis fungoides & Sezary syndrome dermatopathic lymphadenopathy myeloid sarcoma follicular lymphoma grading; WHO nodal marginal zone lymphoma; IHC heavy chain disease normal lymphoid tissue; IHC histiocytic/dendritic neoplasms NOTCH1 mutations histiocytic necrotizing lymphadenitis PD-1/CD279 IHC Hodgkin lymphoma pediatric follicular lymphomas IHC interpretation; pitfalls primary effusion lymphoma in situ follicular lymphoma; IHC sarcoidosis infectious lymphadenitis spenic cysts &other non-hematopoietic lesions Langerhans cell histiocytosis/sarcoma Stark law